186 related articles for article (PubMed ID: 27003362)
21. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
24. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
25. Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.
Jaiswal PK; Koul S; Shanmugam PST; Koul HK
Sci Rep; 2018 May; 8(1):7459. PubMed ID: 29748619
[TBL] [Abstract][Full Text] [Related]
26. Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest.
Qiao WL; Hu HY; Shi BW; Zang LJ; Jin W; Lin Q
Oncol Rep; 2016 Jun; 35(6):3409-18. PubMed ID: 27109614
[TBL] [Abstract][Full Text] [Related]
27. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
Xu J; Wu W; Wang J; Huang C; Wen W; Zhao F; Xu X; Pan X; Wang W; Zhu Q; Chen L
Oncol Rep; 2017 Feb; 37(2):1052-1058. PubMed ID: 28000899
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
29. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
30. Adiponectin inhibits migration and invasion by reversing epithelial‑mesenchymal transition in non‑small cell lung carcinoma.
Cui E; Guo H; Shen M; Yu H; Gu D; Mao W; Wang X
Oncol Rep; 2018 Sep; 40(3):1330-1338. PubMed ID: 29956809
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
32. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition.
Zhang L; Quan H; Wang S; Li X; Che X
Tumour Biol; 2015 Sep; 36(10):8121-6. PubMed ID: 25983004
[TBL] [Abstract][Full Text] [Related]
33. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
Huang J; Sun C; Wang S; He Q; Li D
Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
[TBL] [Abstract][Full Text] [Related]
34. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
37. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Gremlin promotes non-small cell lung cancer progression.
Yin Y; Yang Y; Yang L; Yang Y; Li C; Liu X; Qu Y
Tumour Biol; 2016 Feb; 37(2):2597-602. PubMed ID: 26392110
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
40. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]